(1) Prince M, Wimo A, Guerchet M, Ali GC, Wu YT, Prina M. World Alzheimer Report 2015. The Global Impact of Dementia. Alzheimer’s Disease International. Alzheimer’s Disease International (ADI), London 2015.
(2) Wimo A, Guerchet M, Ali G, Wu Y, Prina AM, Winblad B, et al. The worldwide costs of dementia 2015 and comparisons with 2010. Alzheimer's & Dementia 2017;13(1):1-7.
(3) World Health Organization. Dementia: a public health priority. Dementia 2012.
(4) Ritchie K, Kildea D. Is senile dementia" age-related" or" ageing-related"?—evidence from meta-analysis of dementia prevalence in the oldest old. The Lancet 1995;346(8980):931-934.
(5) Verghese PB, Castellano JM, Holtzman DM. Apolipoprotein E in Alzheimer's disease and other neurological disorders. The Lancet Neurology 2011;10(3):241-252.
(6) Norton S, Matthews FE, Barnes DE, Yaffe K, Brayne C. Potential for primary prevention of Alzheimer's disease: an analysis of population-based data. The Lancet Neurology 2014;13(8):788-794.
(7) Deckers K, van Boxtel MP, Schiepers OJ, de Vugt M, Muñoz Sánchez JL, Anstey KJ, et al. Target risk factors for dementia prevention: a systematic review and Delphi consensus study on the evidence from observational studies. Int J Geriatr Psychiatry 2015;30(3):234-246.
(8) Livingston G, Sommerlad A, Orgeta V, Costafreda SG, Huntley J, Ames D, et al. Dementia prevention, intervention, and care. The Lancet 2017;390(10113):2673-2734.
(9) Kivipelto M, Solomon A, Ahtiluoto S, Ngandu T, Lehtisalo J, Antikainen R, et al. The Finnish geriatric intervention study to prevent cognitive impairment and disability (FINGER): study design and progress. Alzheimer's & Dementia 2013;9(6):657-665.
(10) Vellas B, Carrie I, Gillette-Guyonnet S, Touchon J, Dantoine T, Dartigues JF, et al. MAPT study: a multidomain approach for preventing Alzheimer’s disease: design and baseline data. The journal of prevention of Alzheimer's disease 2014;1(1):13.
(11) Richard E, Van den Heuvel E, van Charante, Eric P Moll, Achthoven L, Vermeulen M, Bindels PJ, et al. Prevention of dementia by intensive vascular care (PreDIVA): a cluster-randomized trial in progress. Alzheimer Disease & Associated Disorders 2009;23(3):198-204.
(12) Richard E, Jongstra S, Soininen H, Brayne C, van Charante, Eric P Moll, Meiller Y, et al. Healthy Ageing Through Internet Counselling in the Elderly: the HATICE randomised controlled trial for the prevention of cardiovascular disease and cognitive impairment. BMJ open 2016;6(6):e010806.
(13) Ngandu T, Lehtisalo J, Solomon A, Levälahti E, Ahtiluoto S, Antikainen R, et al. A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial. The Lancet 2015;385(9984):2255-2263.
(14) Andrieu S, Guyonnet S, Coley N, Cantet C, Bonnefoy M, Bordes S, et al. Effect of long-term omega 3 polyunsaturated fatty acid supplementation with or without multidomain intervention on cognitive function in elderly adults with memory complaints (MAPT): a randomised, placebo-controlled trial. The Lancet Neurology 2017;16(5):377-389.
(15) van Charante, Eric P Moll, Richard E, Eurelings LS, van Dalen J, Ligthart SA, Van Bussel EF, et al. Effectiveness of a 6-year multidomain vascular care intervention to prevent dementia (preDIVA): a cluster-randomised controlled trial. The Lancet 2016;388(10046):797-805.
(16) Ajzen I. The theory of planned behavior. Organ Behav Hum Decis Process 1991;50(2):179-211.
(17) Bandura A. Self-efficacy conception of anxiety. Anxiety Res 1988;1(2):77-98.
(18) Prochaska JO, Velicer WF. The transtheoretical model of health behavior change. American journal of health promotion 1997;12(1):38-48.
(19) Janz NK, Becker MH. The health belief model: A decade later. Health Educ Q 1984;11(1):1-47.
(20) Locke EA, Latham GP. A theory of goal setting & task performance. : Prentice-Hall, Inc; 1990.
(21) Kim S, Sargent-Cox K, Cherbuin N, Anstey KJ. Development of the motivation to change lifestyle and health behaviours for dementia risk reduction scale. Dementia and geriatric cognitive disorders extra 2014;4(2):172-183.
(22) Champion VL, Skinner CS. The health belief model. Health behavior and health education: Theory, research, and practice 2008;4:45-65.
(23) Beaton DE, Bombardier C, Guillemin F, Ferraz MB. Guidelines for the process of cross-cultural adaptation of self-report measures. Spine 2000;25(24):3186-3191.
(24) Costello AB, Osborne JW. Best practices in exploratory factor analysis: Four recommendations for getting the most from your analysis. Practical assessment, research & evaluation 2005;10(7):1-9.
(25) De Vet HC, Terwee CB, Mokkink LB, Knol DL. Measurement in medicine: a practical guide. : Cambridge University Press; 2011.
(26) Field A. Discovering statistics using IBM SPSS statistics. : sage; 2013.
(27) Awang Z. SEM made simple: A gentle approach to learning Structural Equation Modeling. : MPWS Rich Publication; 2015.
(28) Hu L, Bentler PM. Cutoff criteria for fit indexes in covariance structure analysis: Conventional criteria versus new alternatives. Structural equation modeling: a multidisciplinary journal 1999;6(1):1-55.
(29) Dementia Australia. Your brain matters, the power of prevention. Available at: https://yourbrainmatters.org.au/. Accessed 15-2-, 2019.
(30) Edwards PJ, Roberts I, Clarke MJ, DiGuiseppi C, Wentz R, Kwan I, et al. Methods to increase response to postal and electronic questionnaires. The Cochrane Library 2009.
(31) McPeake J, Bateson M, O'Neill A. Electronic surveys: how to maximise success. Nurse Researcher (2014 ) 2014;21(3):24.
(32) Centraal Bureau voor de Statistiek. Bevolking; onderwijsniveau; geslacht, leeftijd en migratieachtergrond. 2019; Available at: https://statline.cbs.nl/StatWeb/publication/?VW=T&DM=SLNL&PA=82275NED&LA=NL. Accessed 20-2-, 2019.